Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Cash from Financing Activities (2023 - 2025)

Historic Cash from Financing Activities for BrightSpring Health Services (BTSG) over the last 3 years, with Q3 2025 value amounting to -$13.1 million.

  • BrightSpring Health Services' Cash from Financing Activities fell 16712.24% to -$13.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$156.9 million, marking a year-over-year decrease of 32337.68%. This contributed to the annual value of $164.6 million for FY2024, which is 31408.32% up from last year.
  • Latest data reveals that BrightSpring Health Services reported Cash from Financing Activities of -$13.1 million as of Q3 2025, which was down 16712.24% from -$8.2 million recorded in Q2 2025.
  • In the past 5 years, BrightSpring Health Services' Cash from Financing Activities registered a high of $154.8 million during Q1 2024, and its lowest value of -$143.9 million during Q4 2023.
  • Moreover, its 3-year median value for Cash from Financing Activities was -$8.2 million (2025), whereas its average is -$1.8 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first surged by 72201.28% in 2024, then crashed by 16712.24% in 2025.
  • Quarter analysis of 3 years shows BrightSpring Health Services' Cash from Financing Activities stood at -$143.9 million in 2023, then surged by 65.58% to -$49.6 million in 2024, then skyrocketed by 73.55% to -$13.1 million in 2025.
  • Its last three reported values are -$13.1 million in Q3 2025, -$8.2 million for Q2 2025, and -$86.0 million during Q1 2025.